Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 303

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 303
---
 determined that this test was met in connection with the Business Combination as described in the section titled “ Proposal No. 1 — The Business Combination Proposal — Satisfaction of 80% Test ” in this proxy statement/prospectus.

<div align='center'>161</div>

TABLE OF CONTENTS

#### Redemption Rights
Iris will provide its public stockholders with the opportunity to redeem all or a portion of their shares of Iris Class A Common Stock upon the completion of the Business Combination at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Business Combination including interest earned on the funds held in the Trust Account not previously released to Iris to pay taxes, divided by the number of then outstanding shares of Iris Class A Common Stock, subject to certain limitations. The amount in the Trust Account is anticipated to be approximately $2,001,033, or $11.47 per share (as adjusted for redemptions paid out of the Trust Account in January 2025 and net of all applicable taxes payable from the Trust Account) of Iris Class A Common Stock. Iris’s sponsor, officers, and directors have entered into a Sponsor Agreement with Iris, ParentCo and Liminatus, pursuant to which they have agreed not to exercise their redemption rights with respect to any Founder Shares and public shares they may hold in connection with the completion of the Business Combination.

You will be entitled to receive cash for any shares of Iris Class A Common Stock to be redeemed only if you:

(i)

(a) hold Iris Class A Common Stock, or (b) hold Iris Units and you elect to separate your such Iris Units into the underlying shares of Iris Class A Common Stock and Public Warrants prior to exercising your redemption rights with respect to the Iris Class A Common Stock; and

(ii)

prior to 5:00 p.m., Eastern Time, on February 28, 2025 (two Business Days prior to the vote at the Special Meeting), (a) submit a written request to the Transfer Agent that Iris redeem your shares of Iris Class A Common Stock for cash and (b) deliver your shares of Iris Class A Common Stock to the Transfer Agent, physically or electronically through DTC.

As noted above, holders of Iris units must elect to separate the underlying Iris Class A Common Stock and Public Warrants prior to exercising redemption rights with respect to the Iris Class A Common Stock. If holders hold their Iris units in an account at a brokerage firm or